Taste Masking
Developing novel pharmaceutical technology that provides for outstanding taste masking for a broad range of pharmaceuticals including major drug categories such as NSAIDS and statins.
News
28 April 2010
International patent applications made for Chewitab™, novel gels,
syrups and suspension systems
Oxford Nutrascience Group plc ("Oxford Nutrascience" or "the Company") announces that it has filed two international patent applications. The submission of the patents, which are in line with the milestones as outlined in the Company's admission document dated 8 February 2010, will cover more than 130 countries.
PCT application no PCT/GB2010/050674, entitled "Chewable Oral Delivery System", covers the novel chewable tablet technology for vitamins and medicines developed by the Company. Initially the Company intends to launch of a range of Chewitab™ products including a chewable calcium supplement and a chewable multi-vitamin supplement. It will also be seeking to license its tablet technology to major consumer healthcare companies in the global over-the-counter (OTC) and prescription pharmaceutical sectors
PCT application no PCT/GB2010/050673, entitled "Delivery System", covers the novel gels, syrups and suspension systems developed by Oxford Nutrascience. These products will also be commercialised by licensing the Company's intellectual property to major brand owners in the OTC and prescription pharmaceutical sectors.
Both applications claim priority from the delivery system patent application which Oxford Nutrascience filed in April 2009. They are expected to be published in October 2010. Following initial examination in the international phase, these will, in due course be turned into national and regional patent applications in the countries of interest.
Marcelo Bravo, Executive Chairman and Chief Technology Officer commented,
"These two international patent applications are an important step in the continued advancement of the commercialisation of our technology.
"We now have two very robust patent applications for the business's key technologies, namely chewable tablets and liquid suspensions and gels. Both these technologies deliver unique advantages in dispersion and solubilisation of medicines, improved taste and mouth feel and manufacturing process simplification."
For further information:
| Oxford Nutrascience Group Plc | |
| Nigel Theobald, Chief Executive | +44 1865 854874 |
| Mark Way, Investor and Media Relations | +44 7786 116991 |
| ZAI Corporate Finance (Nominated Adviser) | |
| John Depasquale | +44 20 7060 2220 |
| Sarang Shah | +44 20 7060 2220 |
About Oxford Nutrascience Group Plc
- Oxford Nutrascience is a UK consumer healthcare company that develops chewy confectionery, chewable tablets and liquid suspensions to allow medicines and vitamin supplements to be taken in a more pleasant and convenient way.
- Oxford Nutrascience has developed technology for the use of prebiotic soluble fibres in medicine delivery systems that disperse and solubilise medicines, improve taste and mouth feel, simplify processing and eliminate additives, incorporate prebiotic health benefits.
- Chews: Oxford Nutrascience currently produces Ellactiva®, a calcium chewy supplement sold in the UK and in the Middle East, and plans to launch new chews to complement this existing product.
- Chewable tablets and liquid suspensions: The target market for Oxford Nutrasciences' Chewitabs™ and liquid suspension delivery systems are over-the-counter ("OTC") pain relieving drugs, indigestion preparations and cough and cold medicines.